Advertisement


Biontech
World  /  Published 20.06.22

Parents face jab dilemma

It’s a moment many parents have anxiously awaited for months: Children younger than five years are now eligible for vaccination against the coronavirus, among the last Americans to qualify. Wit...
By Apoorva Mandavilli

Science Tech  /  Published 07.03.22

Battle of Memories

As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: how soon before they need yet another shot? Not for many mont...
By Apoorva Mandavilli

Science Tech  /  Published 23.02.22

Africa: Tangle quest to make mRNA vaccine

Last week's European Union-African Union summit brought conflicting news about mRNA vaccine production in Africa. Two days after BioNTech executives announced plans to export a version of its Mar...
By Deutsche Welle

India  /  Published 27.01.22

Omicron booster for better immunity: Study

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...
By GS Mudur in New Delhi

World  /  Published 22.01.22

Boosters key to Covid fight

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...
By Apoorva Mandavilli in New York

Advertisement

World  /  Published 22.10.21

Pfizer booster jab

Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their Covid-19 vaccine against the virus, including the Delta var...
By Reuters in Berlin

India  /  Published 21.09.21

India won't buy Pfizer, Moderna jabs: Report

India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccin...
By Reuters in New Delhi

India  /  Published 20.09.21

Pfizer-BioNTech vaccine safe for kids of 5-11 yrs

Global pharma major Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralizing antibody response in children aged five to 11 years,...
By Our bureau and PTI in New Delhi

World  /  Published 18.08.21

Jab effective against Delta variant

The Delta variant of the SARS-CoV-2 virus, that causes Covid-19, is unable to evade the antibodies generated by vaccination, according to a lab study. The findings, published in the journal Immunity,...
By Our Bureau, PTI in Washington

World  /  Published 24.07.21

Pfizer: longer gap boosts immunity

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University ...
By H S Rao in London


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.